TD Cowen Lowers Avantor (NYSE:AVTR) Price Target to $12.00

Avantor (NYSE:AVTR) had its target price reduced by investment analysts at TD Cowen from $14.00 to $12.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. TD Cowen’s price target would indicate a potential downside of 0.58% from the stock’s previous close.

A number of other research analysts have also issued reports on the company. Raymond James Financial lowered Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. Robert W. Baird raised their price objective on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $12.00 price objective (down previously from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Monday, December 29th. Finally, UBS Group set a $12.00 price target on shares of Avantor in a research note on Thursday, October 30th. Three analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Avantor presently has an average rating of “Hold” and a consensus target price of $13.60.

Avantor Price Performance

Shares of NYSE AVTR opened at $12.07 on Wednesday. The stock has a market capitalization of $8.23 billion, a price-to-earnings ratio of -92.85, a PEG ratio of 4.19 and a beta of 0.93. Avantor has a 12 month low of $10.62 and a 12 month high of $23.32. The firm’s 50 day simple moving average is $11.43 and its 200-day simple moving average is $12.61. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.49 and a quick ratio of 0.96.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the prior year, the firm earned $0.26 earnings per share. The business’s revenue for the quarter was down 5.3% on a year-over-year basis. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Analysts expect that Avantor will post 1.06 EPS for the current year.

Insider Buying and Selling at Avantor

In other Avantor news, Director Gregory L. Summe purchased 100,000 shares of the firm’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average cost of $11.25 per share, with a total value of $1,125,000.00. Following the purchase, the director owned 300,000 shares in the company, valued at approximately $3,375,000. This represents a 50.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Sanjeev K. Mehra acquired 350,000 shares of the company’s stock in a transaction dated Friday, December 5th. The shares were purchased at an average price of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the acquisition, the director owned 350,000 shares in the company, valued at approximately $3,881,500. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 1.20% of the company’s stock.

Institutional Trading of Avantor

Hedge funds have recently made changes to their positions in the stock. TD Private Client Wealth LLC lifted its holdings in shares of Avantor by 9.2% in the third quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock valued at $100,000 after buying an additional 670 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after buying an additional 905 shares during the period. Truist Financial Corp raised its holdings in shares of Avantor by 2.2% during the second quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock worth $597,000 after acquiring an additional 959 shares in the last quarter. TD Waterhouse Canada Inc. grew its stake in shares of Avantor by 2.5% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company’s stock valued at $532,000 after buying an additional 966 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Avantor by 2.7% during the second quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock worth $499,000 after buying an additional 979 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.